4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000160
CEO & President sold 1,565 shares at $457.00 ($715,205)
- CEO & President acquired 1,565 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Kewalramani Reshma · CEO & President
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,565 | $187.53 | $293,484 | 122,939 | D |
| 2024-05-24 | Sale : show line 2 in the form 10b5-1 | −1,565 | $457.00 | $715,205 | 121,374 | D |
| Open-market sales · 1,565 sh · avg $457.00 · $715,205 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-05-24 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,565 | $187.53 | 2029-02-05 | 1,565 | 0 | D |
Loading xslF345X05/wk-form4_1717013304.xml…